GSK

#7031
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
59.1200
+1.34%
Setor:
Base:
Moeda do lucro:
Faixa diária
58.9350
59.1500
Faixa anual
42.8850
61.6950
Mudança diária
+1.34%
Mudança mensal
+17.84%
Mudança em 6 meses
+34.82%
Mudança anual
+34.82%
Fechamento anterior
58.3400
Open
58.9350
Bid
Ask
Low
58.9350
High
59.1500
Volume
2 358
Open full chart

Financials

Overview Relatórios Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24 TTM

GSK plc American Depositary Shares (Each representing two Ordin

GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England. GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500. The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK. The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost.

Notícias